Jade Biosciences, Inc. · NASDAQ:JBIO
Deep Track Capital, LP reported a 6.99% stake in Jade Biosciences, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Deep Track Capital, LP reported a 6.99% stake in Jade Biosciences, Inc., 2,279,892 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 6.99%
- Shares
- 2,279,892
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 6.99% | 2,279,892 |
| Deep Track Biotechnology Master Fund, Ltd. | 6.99% | 2,279,892 |
| David Kroin | 6.99% | 2,279,892 |
Source
Related
- Jade Biosciences, Inc.
- Deep Track Capital, LP
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Feb 13, 2026
- Schedule 13G · Deep Track Capital, LP · Jun 20, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026